Collegium Pharmaceutical, Inc.

NasdaqGS:COLL Stock Report

Market Cap: US$1.1b

Collegium Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:COLL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Aug 25SellUS$671,576Thomas SmithIndividual17,478US$38.42
13 Aug 25SellUS$946,250Rubric Capital Management LPCompany25,000US$37.85
08 Aug 25SellUS$400,641John FreundIndividual11,659US$34.36
06 Mar 25SellUS$1,303,474Shirley KuhlmannIndividual46,067US$28.50

Insider Trading Volume

Insider Buying: COLL insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of COLL?
Owner TypeNumber of SharesOwnership Percentage
State or Government8,2830.023%
Individual Insiders262,9270.729%
Hedge Funds3,132,7438.68%
Institutions32,679,00290.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 90.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17%
BlackRock, Inc.
5,341,828US$192.3m-2.06%no data
9.94%
Rubric Capital Management LP
3,132,743US$112.8m-0.79%1.45%
8.38%
Eventide Asset Management, LLC
2,641,401US$95.1m0.07%1.51%
7.14%
The Vanguard Group, Inc.
2,248,211US$80.9m0.07%no data
4.83%
Renaissance Technologies LLC
1,521,170US$54.8m-5.87%0.07%
4.66%
Principal Global Investors, LLC
1,467,775US$52.8m-6.71%0.02%
4.54%
Fuller & Thaler Asset Management, Inc.
1,431,029US$51.5m4.34%0.17%
4.3%
State Street Global Advisors, Inc.
1,354,417US$48.8m-1.5%no data
3.33%
Invesco Ltd.
1,049,127US$37.8m7.42%0.01%
3.29%
Emerald Advisers, LLC
1,035,355US$37.3m-25.4%0.71%
2.73%
Dimensional Fund Advisors LP
861,191US$31.0m-5.26%no data
2.52%
Massachusetts Financial Services Company
793,934US$28.6m-0.66%0.01%
2.48%
Geode Capital Management, LLC
780,243US$28.1m1.92%no data
1.7%
Invesco Capital Management LLC
535,744US$19.3m-18.3%0.01%
1.61%
Victory Capital Management Inc.
508,756US$18.3m2.01%0.01%
1.49%
Janus Henderson Group plc
469,549US$16.9m9.08%0.01%
1.42%
Bank of America Corporation
448,853US$16.2m15.6%no data
1.23%
Charles Schwab Investment Management, Inc.
386,100US$13.9m0%no data
1.21%
Northern Trust Global Investments
380,787US$13.7m-1.34%no data
1.11%
LSV Asset Management
349,900US$12.6m-8.89%0.02%
1.07%
Pacer Advisors, Inc.
337,667US$12.2m-19.4%0.03%
1.07%
Loomis Sayles & Company, L.P.
337,137US$12.1m79.9%0.01%
1.03%
UBS Asset Management AG
325,823US$11.7m13.3%no data
1%
Morgan Stanley
316,273US$11.4m2.59%no data
0.97%
Royce & Associates, LP
305,812US$11.0m1.06%0.1%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/02 07:14
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Collegium Pharmaceutical, Inc. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dana FlandersGuggenheim Securities, LLC
Antonio ArceH.C. Wainwright & Co.
Oren LivnatH.C. Wainwright & Co.